Pharma Deadline Extended: Govt Grants Relief to Small & Medium Firms
The Ministry of Health & Family Welfare has given three months from February 11, 2025, to the small and medium pharmaceutical firms to submit their plan for upgradation to the…
Two arrested as Haryana cracks down on online suppliers of abortion kits
Two Uttar Pradesh-based online pharmacy owners were arrested on Wednesday for allegedly supplying medical termination of pregnancy (MTP) kits to Gurugram following a joint operation by Haryana’s Police and health…
IIT Madras bags new patent on breast cancer treatment using nanocarriers
NEW DELHI: IIT Madras has patented a breakthrough drug delivery system aimed at treating breast cancer, one of the leading causes of death among women worldwide. The innovative solution, developed by the…
NATCO Pharma Q3 Results: Profit declines 37% to Rs 132 crore
NATCO Pharma Ltd on Wednesday reported a 37.75 per cent decline in consolidated net profit to Rs 132.4 crore in the December quarter, hit by a drop in formulations exports.…
Natco Pharma Gets USFDA Approval for Bosentan 32mg Tablets
Natco Pharma Ltd has received final approval from the USFDA to market Bosentan 32 mg tablets. This drug, Bosentan 32 mg tablets is used for the treatment of pulmonary arterial…
Astrazeneca Pharma gains after Q3 PAT soars to Rs 55 cr
Astrazeneca Pharma India advanced 1.21% to Rs 7557.05 after the company’s standalone net profit surged to Rs 54.68 crore in Q3 FY 25 as compared with Rs 15.80 crore in…
Pharma companies turn to AI to speed up drug development, but hit hurdles
When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals, its scientists thought they had a future lung medicine in their hands. Artificial intelligence came up with another plan. It was…
Nifty Pharma drops over 2%, 19 index stocks tumble up to 7%. What triggered this fall?
Stock Market Today: Indian pharma stocks faced significant selling pressure in today’s session, February 10, driven by weak earnings in select companies and fears that former U.S. President Donald Trump…
Glenmark secures MHRA approval to launch Winlevi in the UK
Glenmark Pharmaceuticals (Glenmark) has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market Winlevi in the United Kingdom. The topical treatment for acne vulgaris is approved…
Drug association ties up with NIPER to set up pharma research centre in Baddi
Facing challenges to access essential technical services, quality testing, research and development, besides regulatory services at competitive rates, a Contract Research Organisation (CRO)-cum-Centre of Excellence is being set up at…
